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Crystal structureHimastatin is a novel antibiotic featuring a bicyclohexadepsipeptide structure. On the himastatin
biosynthesis pathway, three cytochrome P450s (HmtT, HmtN, HmtS) are responsible for the post-tai-
loring of the cyclohexadepsipeptide backbone. Here we report the crystal structures of HmtT and
HmtN. The overall structures of these two proteins are homologous to other cytochrome P450s.
However, the exceptionally long F–G loop in HmtT has a highly unusual conformation and extends
deep into the active site. As a result, the F/G helices of HmtT are both kinked. In contrast, the F/G heli-
ces of HmtN are straight. Also, the F/G helices in HmtT and HmtN take distinctive orientations, which
may be a contributing factor for the substrate speciﬁcity of these two enzymes.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Himastatin is a novel antibiotic produced through fermentation
of Streptomyces hygroscopicus [1,2]. It inhibits Gram-positive bacte-
ria, including methicillin-resistant Staphylococcus aureus (MRSA),
but not Gram-negative bacteria. It is cytotoxic to mammalian tu-
mor cells, which leads to increased life span of mice inoculated
with P388 leukemia and B16 melanoma cells [2]. However, its
anti-tumor ability is limited to the localized cells. The distal site
antitumor activity is not observed. The antibacterial activity of
himastatin can be inhibited through mixing with mouse liver S9
fraction, which is due to the presence of fatty acid sodium salts.
It has been shown that himastatin is trapped in the micellesformed by the salts. The physical interactions, instead of chemical
reactions, may explain its lack of distal site antitumor activity [3].
Himastatin belongs to the depsipeptide group whose members
are formed by replacing one or more amide bonds on the peptide
backbone with ester bonds [4]. A good example of depsipeptide
is found in the vancomycin resistant bacterial’s cell wall where
the L-Lys-D-Ala-D-Lac motif disrupts the binding of vancomycin
and causes the antibiotic resistance [5]. The structure of himastatin
harbors an unusual symmetric cyclohexadepsipeptide dimer. The
residues on the depsipeptide ring take alternating D or L conﬁgura-
tions. Such arrangement is important for its activity as the change
on the stereochemistry of tryptophan residue inactivates himasta-
tin [6]. Attached to the cyclic backbone are several tailoring groups,
such as hydroxypiperazic acid and hexahydropyrroloindole moie-
ties [7]. The peptidyl backbone of this cyclodepsipeptide implies
that it is synthesized by large, multiple-module non-ribosomal
peptide synthetases (NRPSs). The structural diversity is achieved
through backbone modiﬁcation by various tailoring enzymes be-
fore or after the ring formation [8]. The gene cluster for the biosyn-
thesis of himastatin contains several typical NRPSs that are
responsible for the peptide formation. Also included in the cluster
are three cytochrome P450 (CYP) proteins (HmtT, HmtN, HmtS) in-
volved in the tailoring process (Fig. 1) [9]. These three cytochrome
Fig. 1. Reactions catalyzed by HmtT, HmtN and HmtS. HmtT catalyzes the formation of hexahydropyrroloindole from L-tryptophan, HmtN catalyzes the hydroxylation of
piperazic acid group and HmtS is responsible for the aromatic coupling of cyclohexadepsipeptide monomers. The functional groups involved in the reactions are colored in
red.
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hexahydropyrroloindole from L-tryptophan. Chemically, the pyrro-
loindole group can be synthesized by cyclization of N-(2-haloben-
zyl)pyrroles catalyzed by Pb-based catalyst [10]. However, no
biosynthetic approach has been reported for this chemical except
for the HmtT-catalyzed reaction. HmtN is responsible for the
hydroxylation of an unusual piperazic acid (Pip) motif [9]. The
Pip motif is found in many important secondary metabolites, such
as azinothricin, kettapeptin, antrimycin and monamycin [11–13].
Although the chemical synthesis of Pip motif has been achieved
using different routes, the biosynthesis of Pip stays unclear [14].
Even less is known about the modiﬁcation on the Pip residue after
it is formed. The last tailoring enzyme on the himastatin biosyn-
thesis pathway, HmtS, catalyzes the aromatic coupling between
cyclic depsipeptide monomers. This reaction is critical for the
himastatin activity as the depsipepide monomer is inactive [6].
Although the biological functions of HmtT and HmtN have been
reported, the structural aspects of these proteins have not been
studied. Here we present the crystal structures of HmtT and HmtN.
The structure of HmtT harbors an unusual lid region (F helix, G he-
lix and F–G loop) that penetrates deep into the active site. Compar-
ison of HmtT and HmtN structures demonstrates that F/G helices in
these two proteins adopt distinctive orientations that may contrib-
ute to their ability to distinguish homologous substrates with sub-
tle difference.
2. Materials and methods
2.1. Protein expression and puriﬁcation
The hmtT and hmtN genes were PCR-ampliﬁed and ligated into
pGEM-T vector and sequenced for correction. Then the correct
hmtT and hmtN genes were ligated into pET-28a vector and trans-
formed into E. coli strain BL21(DE3).
The recombinant strains were incubated in Luria Bertani (LB)
broth with kanamycin (50 lg/mL) and induced by isopropyl b-D-
1-thiogalactopyranoside (IPTG) (0.1 mM) when the optical density
at 600 nm (OD600) reached 0.5. The cells were collected by centri-
fugation and lysed by cell disruption instrument (Constant System
Ltd.). And the supernatant was collected by centrifugation at 4 C,
12,000 rmin1 for 30 min.
The supernatant was applied to Ni–NTA Resins (GE Healthcare)
pre-equilibrated with buffer containing 20 mM Tris–HCl, pH 8.3,
500 mM KCl. The column was washed with pre-equilibrium buffersupplemented with 30 mM imidazole. After elution with pre-equi-
librium buffer supplemented with 200 mM imidazole, the His-tags
on the recombinant proteins were removed with thrombin (1 unit/
mg, Sigma). The proteins were dialyzed with pre-equilibrium buf-
fer and applied to a Superdex 75 column (16/60, GE Healthcare)
equilibrated with Tris–HCl buffer (20 mM Tris–HCl, pH 8.3,
200 mM KCl). The puriﬁed proteins were concentrated by 10 K,
Amicon Ultra-4 Centrifugal Filter Units before the concentrations
were estimated spectrometrically at OD280.
2.2. UV–visible spectrophotometry
All spectra for HmtT and HmtN were obtained with an UV-
1800PC spectrophotometer (MAPADA). The baseline was zeroed
between 390 and 700 nm and the UV–visible spectra of sub-
strate-free enzymes (HmtT and HmtN, 0.2 mg/mL in Tris–HCl buf-
fer) were recorded. The protein–imidazole complex was
generated by adding imidazole (100 mM) to the enzyme solution
in the same buffer. Then the spectra were measured under the
same condition.
2.3. CO difference spectra
A solution of the enzyme in Tris–HCl buffer was divided be-
tween two separate cuvettes (sample and reference). CO gas was
bubbled through the sample cuvette for 30 s, and then 2 mg of so-
lid sodium dithionite was added to each cuvette before a difference
spectrum was recorded.
2.4. Crystallization and data collection
Crystals of HmtT and HmtN were grown by the sitting drop va-
por diffusion method. HmtT (1 lL at 20 mg/mL) was mixed with
the precipitant solution (0.1 M Sodium acetate trihydrate, pH 4.6,
8% (w/v) polyethylene glycol (PEG)-4000 and 3% (v/v) dimethyl
sulfoxide). The crystals of HmtT appeared after 4 days incubation
at 4 C and reached their maximum size 20 days later. They were
soaked in the cryoprotectant containing the precipitant solution
and 40% (w/v) D-(+)-trehalose dehydrate (Fluka) before frozen in li-
quid nitrogen. And 1 lL of HmtN (20 mg/mL) was mixed with the
precipitant solution (0.1 M sodium cacodylate, pH 6.5, 10% (w/v)
PEG-3000 and 0.2 M MgCl2). The crystals of HmtN appeared after
overnight incubation at 4 C and reached their maximum size
6 days later. The crystals of HmtN were soaked in the cryoprotec-
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ros) before frozen in liquid nitrogen.
Diffraction data were collected at 100 K from HmtT crystals
with an ADSC Q315 CCD detector on beam-line BL17U, Shanghai
synchrotron radiation facility (SSRF), Shanghai, China. Diffraction
data of HmtN were collected from a rotating anode X-ray source
(Rigaku 007 & IP IV++/CCD944+) in the Institute of Biophysics, Chi-
nese Academy of Sciences, Beijing, China. The data set of HmtT was
indexed with XDS package and scaled with Scala [15]. The data set
of HmtN was indexed using Mosﬂm [16].
The structures of HmtT and HmtN were solved by molecular
replacement using the program Phaser with the EryK (PDB ID:
2JJN) as the search model. The auto-model building was done with
Phenix package, which was followed by the manual model building
performed with Coot [17,18]. Along the manual building process,
reﬁnement was done with Phenix and Refmac5 [18,19].
2.5. Data deposition
The atomic coordinates and the structure factors of HmtT and
HmtN were deposited in the Protein Data Bank (www.rcsb.org)
with the accession codes of 4GGV and 4E2P, respectively.
3. Results and discussion
3.1. Sequence analysis
The sequences of ﬁve cytochrome P450s were aligned using
Clustal X [20] (Fig. 2). HmtT and HmtN share 55% identity while
HmtT and HmtS have 51% identity. Although these cytochrome
P450s have high homology with each other, some noticeable differ-
ence can be found in the F–G loop region. HmtT, HmtN and HmtS
have an F–G loop of the same length while the loops in EryK from
Saccharopolyspora erythraea and P450BioI (CYP107H1) from Bacillus
subtilis are much shorter. The additional residues in the F–G loop
could increase the ﬂexibility of this region, which may facilitate
the transportation of exceptionally large substrates of these en-
zymes [21,22].
3.2. Spectroscopy analysis
The UV–visible spectroscopic scan of HmtT resulted in a typical
low-spin ferric state CYP absorption spectrum. The Soret band is
found at 417.0 nm. The b/a bands are located at 535.0 and
565.0 nm respectively. In the presence of imidazole, the Soret band
moved to 424.0 nm, while b and a bands moved to 544.5 andFig. 2. Structure-based sequence alignment of the cytochrome P450 proteins HmtT, HmtN
the Eryk sequence from Saccharopolyspora erythraea and the P450BioI sequence from Bacil
HmtT. Arrows represent b-strands and helices represent a-helices. The conserved residu562.5 nm respectively. The UV–visible spectroscopic scan of HmtN
shows a similar spectrum as that of HmtT. Within the spectrum, a
Soret band is found at 419 nm and the b/a bands are located at
535.5 and 566.0 nm respectively. Meanwhile, in the presence of
imidazole, the Soret band shifted to 423.5 nm, and b/a bands
shifted to 541.0 and 565.0 nm respectively. This indicates that
the imidazole molecule removes the water molecule associated
with the heme group and binds it as the axial ligand. Also, the
CO difference spectra of HmtT and HmtN show a prominent peak
at 450 nm (The spectra will be provided on request).
3.3. The overall structure of HmtN
The structures of HmtT and HmtN were solved by molecular
replacement with the EryK (PDB ID: 2JJN) as the search model.
The statistics for data collection and reﬁnement are summarized
in Table 1. As expected, HmtN adopts the typical prism-shape
structure of cytochrome P450s which consists of 12 a helices and
14 b strands (Fig. 3A) [23]. The heme prosthetic group is sand-
wiched between I helix and cysteine-ligand loop. The active site
of HmtN lies at the center of the prism where the heme prosthetic
group is located (Fig. 3A). The active site conﬁguration is main-
tained through a network of hydrogen bonds between adjacent
structural elements. The heme group forms hydrogen bonds with
C helix, K helix, b7 strand and cysteine–ligand loop. The enclosed
cysteine residue acts as a proximal ligand for the heme group.
On the other side, a water molecule is connected to the heme
through a coordinate bond.
A visible feature at the active site of cytochrome P450s is the
long I helix extending across the whole molecule. On this helix,
most cytochrome P450s contain a small acidic residue next to a
highly conserved Thr residue, which is vital for the oxygen activa-
tion [24,25]. However, the acidic residue is not found on the HmtN
sequence. Instead, a non-polar Leu occupies the place. This kind of
variance is also found in the sequence of another hydroxylase EryK
that shows high structural similarity with HmtN (Fig. 2). It was
proposed that the Thr and the acidic residue form a proton delivery
network. The acidic residue has the function of relaying protons
[25]. In the HmtN structure, several water molecules form a hydro-
gen-bond network. This network may deliver the protons into the
active site.
3.4. The overall structure of HmtT
Like HmtN, the overall structure of HmtT adopts a typical fold of
cytochrome P450s (Fig. 3B). A striking feature in the HmtT struc-, HmtS, EryK and P450BioI. The sequences of HmtT, HmtN and HmtS are aligned with
lus subtilis. The sequences are annotated with corresponding secondary structures in
es are colored in red.
Table 1
Data collection and reﬁnement statistics of HmtT and HmtN.
HmtT HmtN
Data collection
Space group P21212 P212121
Cell dimensions
a, b, c (Å) 64.41, 121.14, 54.73 56.14, 72.29, 103.29
a, b, c () 90.00, 90.00, 90.00 90.00, 90.00, 90.00
Resolution (Å) 44.12–2.33 18.38–2.36
Wavelengths (Å) 0.9792 1.5418
Rmerge
a 0.071 (0.383) 0.036(0.078)
I/r(I) 18.27 (6.08) 17.10 (9.60)
Completeness (%) 99.9 (94.2) 98.3 (96.3)
Redundancy 4.3 (4.5) 5.3 (4.8)
Wilson B-factors(Å) 24.89 16.48
Reﬁnement
Resolution (Å) 44.12–2.33 (2.37–2.33) 18.38–2.36 (2.42–2.36)











Bond lengths (Å) 0.005 0.005
Bond angles () 0.913 1.458
Ramachandran plotc
Allowed region (%) 2.80 1.65
Favored region (%) 96.70 97.80
Outliers (%) 0.50 0.55
PDB ID 4GGV 4E2P
a Data in the parenthesis was calculated based on the highest resolution shell.
b R-factor = (Rhkl||Fo|  |Fc||)/Rhkl|Fo| where Fo and Fc are the observed and
calculated structure factors respectively. Rfree was calculated with a randomly
selected 5% subset that was excluded from the reﬁnement process.
c Statistics of Ramachandran plot were calculated with MolProbity.
Fig. 3. Three-dimensional structures of HmtN and HmtT. (A) The overall structure of Hmt
cysteine-ligand loop is colored in tan.
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tional residues, the F helix is bent at Ala155 and the G helix is
kinked at Pro187. As a result, the F–G loop is positioned perpendic-
ular to the heme plane (Fig. 4A). The unusual conformation is
maintained through hydrogen bonds between Arg179/Asp66 and
Phe165/Gln76 (Fig. 4B). In the homologous Eryk structure, the G
helix is also kinked due to the presence of Pro192. However, the
proline residue is not conserved in HmtN and P450BioI (Fig. 2).
Therefore, the G helices in these two proteins are straight.
Although F helix of HmtT is kinked at Ala155, this residue is not
found in the HmtN and EryK. The F helices in these two proteins
take a straight conformation. In most cytochrome P450 structures,
the F–G loops lie outside of the active site and serve as a ﬂexible
gate [21,26,27]. In the HmtT structure, as the loop is placed inside
of the active site, it is unlikely to function as a gate. Instead, it may
form a part of the binding site and help to orientate the substrate.
HmtT, HmtN and HmtS target different positions on the cyclo-
hexadepsipeptide backbone [9]. Consequently, the cyclic sub-
strates need to take different orientations in the active site. The
F–G loops in these cytochrome P450s are not conserved, which
are consistent with their possible roles in positioning the corre-
sponding substrates.
The secondary structure comparison performed with Dali server
indicates that the HmtT structure is similar to that of P450BioI from
Bacillus subtilis [28]. P450BioI is the only protein in the PDB database
whose F–G loop adopts a similar conformation as that of HmtT
[22]. In the complex structure of P450BioI and its substrate, the
space directly above the heme prosthetic group is partially occu-
pied by the F–G loop while the substrate reaches the heme group
from the side. Given the structural homology between HmtT and
P450BioI, the HmtT substrate may bind to the active site in a similar
manner, with the B–C loop moving sideways to make room for the
substrate.
3.5. Comparison of HmtT and HmtN structures
The HmtT and HmtN have similar overall structures that are
characteristic of cytochrome P450 family. Superposition of theseN. (B) The overall structure of HmtT. The a helices and b strands are labeled, and the
Fig. 4. Unusual conformations of F helix, G helix and F–G loop in HmtT. (A) Positioning of F–G loop in the active site. The F helix, G helix and F–G loop are colored in cyan and
the heme group is in magenta. The rest of protein is shown as surface and colored in light gray. Unlike other cytochrome P450 proteins, the F–G loop is inserted into the active
site and positioned perpendicular to the heme group. (B) The stabilizing force for the F–G loop. The conﬁguration of F–G loop is maintained with two hydrogen bonds between
Asp66/Arg179 and Phe165/Gln76. The protein is colored in cyan and the heme group is in green. The hydrogen-bond-forming residues are shown in cylinders and colored in
magenta. (C) Diagram showing the different F helix and G helix conformations in HmtT and HmtN. HmtT is colored in cyan and HmtN is colored in green.
H. Zhang et al. / FEBS Letters 587 (2013) 1675–1680 1679two structures results in root mean square deviation (RMSD) of
1.87 over 334 residues. However, the orientations of F helix, G helix
and B–C loop are signiﬁcant different in these two proteins. The F
helix and G helix on HmtN move sideways, which results in an en-
larged entrance for substrate to enter the active site (Fig. 4C).
Although the substrates of HmtT and HmtN are highly homolo-
gous, the functional groups that HmtT and HmtN recognize are lo-
cated at exactly opposite sides of the cyclohexadepsipeptide
backbone (Fig. 1). As a result, the cyclohexadepsipeptide moiety
has to be orientated in the opposite directions relative to the heme
group. This is consistent with the different conﬁgurations of the ac-
tive sites on HmtT and HmtN. Moreover, the F helix, G helix and F–
G loop in HmtT are stabilized by the hydrogen bonds between
Arg179/Asp66 and Phe165/Gln76. The residues Arg179 and
Phe165 are not conserved in HmtN, which may also lead to differ-
ent conformations in the F and G helices.
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